225 related articles for article (PubMed ID: 26436350)
1. The treatment of diabetes mellitus of patients with chronic liver disease.
García-Compeán D; González-González JA; Lavalle-González FJ; González-Moreno EI; Maldonado-Garza HJ; Villarreal-Pérez JZ
Ann Hepatol; 2015; 14(6):780-8. PubMed ID: 26436350
[TBL] [Abstract][Full Text] [Related]
2. Managing diabetes and liver disease association.
Hamed AE; Elsahar M; Elwan NM; El-Nakeep S; Naguib M; Soliman HH; Ahmed Aboubakr A; AbdelMaqsod A; Sedrak H; Assaad SN; Elwakil R; Esmat G; Salh S; Mostafa T; Mogawer S; Sadek SE; Saber MM; Ezelarab H; Mahmoud AA; Sultan S; El Kassas M; Kamal E; ElSayed NM; Moussa S
Arab J Gastroenterol; 2018 Dec; 19(4):166-179. PubMed ID: 30420265
[TBL] [Abstract][Full Text] [Related]
3. [Diabetes mellitus and chronic liver diseases. Literature review (part 2): treatment features].
Kalmykova ZA; Kononenko IV; Mayorov AY
Ter Arkh; 2019 Dec; 91(12):115-121. PubMed ID: 32598598
[TBL] [Abstract][Full Text] [Related]
4. Impact of Incretin-Based Therapies on Adipokines and Adiponectin.
Yaribeygi H; Maleki M; Atkin SL; Jamialahmadi T; Sahebkar A
J Diabetes Res; 2021; 2021():3331865. PubMed ID: 34660808
[TBL] [Abstract][Full Text] [Related]
5. Effects of diabetes drugs on the skeleton.
Meier C; Schwartz AV; Egger A; Lecka-Czernik B
Bone; 2016 Jan; 82():93-100. PubMed ID: 25913633
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Risk in Diabetes Mellitus: Complication of the Disease or of Antihyperglycemic Medications.
Alvarez CA; Lingvay I; Vuylsteke V; Koffarnus RL; McGuire DK
Clin Pharmacol Ther; 2015 Aug; 98(2):145-61. PubMed ID: 25963811
[TBL] [Abstract][Full Text] [Related]
7. Diabetes co-existing with chronic liver disease: clinical features and response to therapy.
Chuhwak EK; Pam SD
Niger J Med; 2007; 16(2):156-60. PubMed ID: 17694770
[TBL] [Abstract][Full Text] [Related]
8. Impaired glucose tolerance in acute pancreatitis.
Kikuta K; Masamune A; Shimosegawa T
World J Gastroenterol; 2015 Jun; 21(24):7367-74. PubMed ID: 26139984
[TBL] [Abstract][Full Text] [Related]
9. Hepatogenous diabetes: Is it a neglected condition in chronic liver disease?
García-Compeán D; González-González JA; Lavalle-González FJ; González-Moreno EI; Villarreal-Pérez JZ; Maldonado-Garza HJ
World J Gastroenterol; 2016 Mar; 22(10):2869-74. PubMed ID: 26973383
[TBL] [Abstract][Full Text] [Related]
10. Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management.
Luo F; Das A; Chen J; Wu P; Li X; Fang Z
Cardiovasc Diabetol; 2019 Apr; 18(1):54. PubMed ID: 31029144
[TBL] [Abstract][Full Text] [Related]
11. Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?
Orsi E; Grancini V; Menini S; Aghemo A; Pugliese G
Liver Int; 2017 Jul; 37(7):950-962. PubMed ID: 27943508
[TBL] [Abstract][Full Text] [Related]
12. Hepatogenous diabetes. Current views of an ancient problem.
García-Compean D; Jaquez-Quintana JO; Maldonado-Garza H
Ann Hepatol; 2009; 8(1):13-20. PubMed ID: 19221528
[TBL] [Abstract][Full Text] [Related]
13. Diabetes Association with Liver Diseases: An Overview for Clinicians.
Hamed AE; Elwan N; Naguib M; Elwakil R; Esmat G; El Kassas M; Abd-Elsalam S; Moussa S
Endocr Metab Immune Disord Drug Targets; 2019; 19(3):274-280. PubMed ID: 30444204
[TBL] [Abstract][Full Text] [Related]
14. The pharmacologic basis for clinical differences among GLP-1 receptor agonists and DPP-4 inhibitors.
Morales J
Postgrad Med; 2011 Nov; 123(6):189-201. PubMed ID: 22104467
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes.
Pratley RE; Salsali A
Curr Med Res Opin; 2007 Apr; 23(4):919-31. PubMed ID: 17407649
[TBL] [Abstract][Full Text] [Related]
16. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors.
Neumiller JJ
J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S16-29. PubMed ID: 19801361
[TBL] [Abstract][Full Text] [Related]
17. Management of postprandial glucose: Recommended targets and treatment with biphasic insulin.
Liebl A
Prim Care Diabetes; 2016 Dec; 10(6):391-397. PubMed ID: 27427307
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant and antiinflammatory activities of curcumin on diabetes mellitus and its complications.
Meng B; Li J; Cao H
Curr Pharm Des; 2013; 19(11):2101-13. PubMed ID: 23116316
[TBL] [Abstract][Full Text] [Related]
19. Insulin therapy and exercise.
Kourtoglou GI
Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S73-7. PubMed ID: 21864755
[TBL] [Abstract][Full Text] [Related]
20. Impact of Blood Glucose Reporting on Glycemic Variability in Veterans With Diabetes.
Mangrum C; Smith L; Shivaswamy V
J Diabetes Sci Technol; 2015 Aug; 9(6):1348-9. PubMed ID: 26285952
[No Abstract] [Full Text] [Related]
[Next] [New Search]
